Ethyl 2-(2-(trifluoromethyl)pyrimidin-5-yl)acetate, 98%, 250mg

Tert-butyl 7,8-dihydropyrido[3,2-d]pyrimidine-5(6H)-carboxylate, 97%, 1g

2-(2-(2-(2-Chloroethoxy)ethoxy)ethoxy)acetic acid, 98%, 1g

1H-Imidazo[4,5-b]pyrazine, 95.0%, 1g

(4S,4'S,5S,5'S)-2,2'-(1-METHYLETHYLIDENE)BIS(4,5-DIHYDRO-4,5-DIPHENYLOXAZOLE), 95%, 100mg

N-Succinimidyl 3-Maleimidopropionate [Cross-linking Reagent]>98.0%(HPLC)(N)100mg

anti-Desmoplakin 1/2 monoclonal de souris, DP 1 + 2-2,15, 0,2 ml

(2E)-1-(4-bromophenyl)-3-[4-(propan-2-yl)phenyl]prop-2-en-1-one, 95.0%, 2g

1-Pyridin-2-yl-ethylamine, 95.0%, 1g

(S)-Ethyl 3-(4-bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoate, 95%, 5g

2-N-Boc-1,2,3,4-Tetrahydro-isoquinoline-1-carboxylic acid, 97.0%, 5g

4-Bromo-5-iodopyridin-2-amine, 95.0%, 5g

Methyl 3-bromo-5-fluorobenzoate, 95.0%, 5g